These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. B cell apoptosis accelerates the onset of murine lupus. Trébéden-Nègre H, Weill B, Fournier C, Batteux F. Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478 [Abstract] [Full Text] [Related]
3. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Morshed SR, Mannoor K, Halder RC, Kawamura H, Bannai M, Sekikawa H, Watanabe H, Abo T. Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339 [Abstract] [Full Text] [Related]
4. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T. Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [Abstract] [Full Text] [Related]
5. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB. Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860 [Abstract] [Full Text] [Related]
6. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice. Li X, Egorina E, Bertelsen EL, Dahlen H, Hannestad K. Scand J Immunol; 2004 Jun; 60(1-2):121-33. PubMed ID: 15238081 [Abstract] [Full Text] [Related]
7. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice. Fredriksen K, Osei A, Sundsfjord A, Traavik T, Rekvig OP. Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573 [Abstract] [Full Text] [Related]
8. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T. Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [Abstract] [Full Text] [Related]
9. Chronical administration of anti-DNA antibodies by subcutaneous injection of hybridoma clones in BALB/c and NZBxNZW/F1 mice. Experimental model of the pathogenic role of DNA in acute lupus disease. Gayral-Taminh M, Delobbe I, Mignon-Conte MA, Dueymes M, Conte JJ. J Clin Lab Immunol; 1992 Feb; 38(3):111-35. PubMed ID: 1345749 [Abstract] [Full Text] [Related]
10. Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice. Norton SD, Harrison LL, Yowell R, Araneo BA. Autoimmunity; 1997 Feb; 26(3):161-71. PubMed ID: 9550284 [Abstract] [Full Text] [Related]
11. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus. Wang X, Huang W, Schiffer LE, Mihara M, Akkerman A, Hiromatsu K, Davidson A. Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860 [Abstract] [Full Text] [Related]
12. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P. J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185 [Abstract] [Full Text] [Related]
13. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice. Zhang Y, Saha S, Rosenfeld G, Gonzalez J, Pepeljugoski KP, Peeva E. J Rheumatol; 2010 Aug 01; 37(8):1646-57. PubMed ID: 20551107 [Abstract] [Full Text] [Related]
14. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Wen X, Zhang D, Kikuchi Y, Jiang Y, Nakamura K, Xiu Y, Tsurui H, Takahashi K, Abe M, Ohtsuji M, Nishimura H, Takatsu K, Shirai T, Hirose S. Eur J Immunol; 2004 Oct 01; 34(10):2740-9. PubMed ID: 15368290 [Abstract] [Full Text] [Related]
15. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A. Arthritis Rheum; 2007 Jun 01; 56(6):1945-53. PubMed ID: 17530718 [Abstract] [Full Text] [Related]
16. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development. Enghard P, Humrich JY, Chu VT, Grussie E, Hiepe F, Burmester GR, Radbruch A, Berek C, Riemekasten G. Eur J Immunol; 2010 Jun 01; 40(6):1809-18. PubMed ID: 20333624 [Abstract] [Full Text] [Related]
17. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody. Ravirajan CT, Wang Y, Matis LA, Papadaki L, Griffiths MH, Latchman DS, Isenberg DA. Rheumatology (Oxford); 2004 Apr 01; 43(4):442-7. PubMed ID: 15024133 [Abstract] [Full Text] [Related]
18. Induction of anti-DNA antibodies in preautoimmune NZBxNZW F1 mice by immunization with a DNA-DNase I complex. Chimenti D, Marchini B, Manzini S, Bombardieri S, Migliorini P. J Autoimmun; 2000 Aug 01; 15(1):9-13. PubMed ID: 10936023 [Abstract] [Full Text] [Related]
19. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice. Lacotte S, Dumortier H, Décossas M, Briand JP, Muller S. J Immunol; 2010 Apr 01; 184(7):3937-45. PubMed ID: 20181885 [Abstract] [Full Text] [Related]
20. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice. Douglas RS, Woo EY, Capocasale RJ, Tarshis AD, Nowell PC, Moore JS. Cell Immunol; 1997 Aug 01; 179(2):126-37. PubMed ID: 9268496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]